Search

… PhD, principle investigator of the ProQR Phase 1/2 STELLAR clinical trial of QR-421a and Professor of Pediatric Surgery, Human …

… Results Top-line data from Phase 2/3 pivotal  Illuminate  trial of sepofarsen for CEP290 -mediated LCA10 on track for … pigmentosa expected to start by year end 2021 Initial clinical data from Phase 1/2 Aurora trial of QR-1123 for … in the pivotal trial of sepofarsen, reported positive clinical data for QR-421a, formed a partnership with Yarrow …

… highlight the potential of Axiomer EONs in preparation for clinical development and supporting discovery of potential … the cost, timing and results of preclinical studies and clinical trials and other development activities by us and … the global market; the likelihood of our preclinical and clinical programs being initiated and executed on timelines …

… of the next phase of the collaboration would enable clinical development of an Axiomer-based therapeutic for Rett … the cost, timing and results of preclinical studies and clinical trials and other development activities by us and … the global market; the likelihood of our preclinical and clinical programs being initiated and executed on timelines …

… the cost, timing and results of preclinical studies and clinical trials and other development activities by us and … partners; the likelihood of our preclinical and clinical programs being initiated and executed on timelines … timely enrollment of subjects and patients to advance our clinical trials and maintain their own operations; our …

… Has Completed 12 Month Visit in Phase 2/3 Illuminate Trial of Sepofarsen Top-line data now expected to be … to, statements regarding sepofarsen (QR-110) and the clinical development and the therapeutic potential thereof, … the cost, timing and results of preclinical studies and clinical trials and other development activities by us and …

… ® RNA editing platform to progress new drug targets toward clinical development and commercialization. ProQR’s unique … the cost, timing and results of preclinical studies and clinical trials and other development activities by us and … or halted by the COVID-19 pandemic; the likelihood of our clinical programs being executed on timelines provided and …

… the cost, timing and results of preclinical studies and clinical trials and other development activities by us and … the global market; the likelihood of our preclinical and clinical programs being initiated and executed on timelines … timely enrollment of subjects and patients to advance our clinical trials and maintain their own operations; our …